Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-20
2007-02-20
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S231500, C514S255050, C514S340000, C514S359000, C544S060000, C544S140000, C544S229000, C546S014000, C546S272100, C548S248000, C548S255000
Reexamination Certificate
active
10512248
ABSTRACT:
The present invention relates to selective NK-1 receptor antagonists of Formula (I); or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins
REFERENCES:
patent: 5998444 (1999-12-01), Russell
patent: 6060478 (2000-05-01), Gilligan et al.
patent: 6407106 (2002-06-01), Jasserand et al.
patent: 0 699 665 (1996-03-01), None
patent: 0 699 665 (2003-03-01), None
patent: 2 329 275 (1976-10-01), None
patent: P2002-123925 (2002-04-01), None
patent: WO 95/11880 (1995-05-01), None
patent: WO 97/40025 (1997-10-01), None
patent: WO 99/07677 (1999-02-01), None
patent: WO 01/44200 (2001-06-01), None
patent: WO 02/08232 (2003-01-01), None
Theocharis, et al. Journal od Heterocyclic Chemistry, vol. 27, pp. 1685-1688 (1990).
Biagi, et al., “N<6>-Cycloalkyl-2-Phenyl-3-Deaza-8-Azaad Nines: A New Class of A1 Adenosine Receptor Ligands. A Comparison With the Corresponding Adenines and 8-Azaadenines”,European J. of Medicinal Chemistry, 38, pp. 983-990 (2003).
Ivanov, et al., “Synthesis of 1,2,3-Triazolo '5,4-e!-1,4-diazepine”,J. of Organic Chemistry of the USSR, XP009037402, 25:9, pp. 1785-1789 (1989).
Katritzky, et al., “Synthesis of C-Carbomoyl-1,2,3-triazoles by Microwave-Induced 1,3-Dipolar Cycloaddition of Organic Azides to Acetylenic Amides”,J. Organ. Chem., XP002299474, 67, pp. 9077-9079 (2002).
Katritzky, et al., “1,3-Dipolar Cycloadditions of Organic Azides to Ester or Benzotriazolylcarbonyl Activated Acetylenic Amides”,ARKIVOC, 15, XP002299475, 15, pp. 47-64 (2003).
L'Abbé, et al., “Synthesis and Thermolysis of 4-Substituted 5-Azido-1-Phenyl-1,2,3-Triazoles”,Tetrahedron, 44:12, pp. 3617-3626 (1988).
Hajjaji, et al., “Synthesis and Evaluation of the Inhibitor Effect of a New Class of Triazole Compounds,”Progress in Organic Coatings, 38, pp. 207-212 (2000).
Abu-Orabi, et al., “Dipolar Cycloaddition Reactions of Organic Azides,”J. Heterocyclic Chem., 26, pp. 1461-1468 (1989).
Theocharis, et al., “Synthesis and Spectral Data of 4,5-Bix[5-aryl-1,3,4-oxadiazol-2-yl]-l-benzyl-1,2,3-triazoles,”J. Heterocyclic Chem, 27, pp. 1685-1688 (1990).
Cottrell, et al., “An Improved Procedure for the Preparation of 1-Benzyl-1H-1,2,3-triazoles from Benzyl Azides,”J. Heterocyclic Chem., 28, pp. 301-304 (1990).
ACS Chemcats 2001:1613994, Publication Date Jan. 7, 2001, Order No. AN-666/14744011, CAS Registry No. 354780-46-4.
Al-Talib, et al., “Synthesis of 4,5-Bis-[5-aryl-1,3,4-oxadiazol-2YL]-1-Substgituted Benzyl-1,2,3-Triazoles,” Indian J. of Heterocyclic Chem., 8, pp. 183-188 (1999).
Amegadzie Albert Kudzovi
Gardinier Kevin Matthew
Hembre Erik James
Hong Jian Eric
Jungheim Louis Nickolaus
Desai Manisha A.
Eli Lilly and Company
Grazier Nyeemah
McKane Joseph K.
LandOfFree
Tachykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tachykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tachykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3811028